Promote Scientific Collaboration
Access to Unique Applications and Tools
HDinHD: Open Source Science for the HD Research Community
The goal of HDinHD is to foster and support a collaborative community united in its drive to accelerate the development of therapeutics that will delay the onset and/or ameliorate the effects of Huntington’s disease. HDinHD seeks to achieve this through:
- Sharing HD-related primary scientific data
- Sharing analyses and computational models built from HD-related scientific data
- Providing browsing and data interrogation tools over both primary and analyzed data that facilitate data exploration and hypothesis generation
- Building a forum for HD researchers to highlight their data, tools, know-how and insight to the community
The HDinHD website is currently a joint development effort by CHDI and UCLA, through the laboratory of Dr. Giovanni Coppola. As you will see when you Register for access, HDinHD highlights data and tools provided by the broader community. If you are interested in Contributing Data to HDinHD, suggest links to other HD-related scientific data or websites, or would otherwise like to provide Feedback to us, we encourage you to do so. HDinHD is for the community; please help us tailor and grow HDinHD in a direction that can make a difference to your research, and ultimately, to improve the lives of HD families.
Latest news and publications from around the HD Ecosystem
- Could molecular handcuffs lower the protein that causes Huntington's disease?
- Exciting new Huntingtin lowering tool described
- Details emerge of first Huntington’s disease gene therapy clinical trial
- Fresh Updates from First Huntingtin Lowering Study Publication
- An Updated Trial Design for Roche's Huntingtin Lowering Trial
- Brain compensation during visuospatial working memory in premanifest Huntington's disease.
- Oxytocin protects against 3-NP induced learning and memory impairment in rats: sex differences in behavioral and molecular responses to the context of prenatal stress.
- Vildagliptin Attenuates Huntington's Disease through Activation of GLP-1 Receptor/PI3K/Akt/BDNF Pathway in 3-Nitropropionic Acid Rat Model.
- Discovery of a potent small molecule inhibiting Huntington's disease (HD) pathogenesis via targeting CAG repeats RNA and Poly Q protein.
- The psychopharmacology of Huntington disease.
- Pick of the Plots: Tuesday 19th November
- Mother suing NHS trust after doctors failed to reveal <b>Huntington's disease</b> risk
- Emmerdale's Lydia gets health shock – but what is <b>Huntington's disease</b>?
- Alkermes Eyes Brain <b>Disorders</b> and Beyond With $100M Deal for Rodin
- Alkermes follows up restructuring with Rodin acqusition